Two big days in a row, I have no idea why, no news, but I like it!! Still think they keep a lid on this because of the overwhelming short position in the stock; many of those Reverse Conversions of the last two weeks are supposedly tied up in the strike level 7 Feb call options. Looking at the open interest on an options chart, it seems plausible. MM will do its best to keep this in check, probably very concerned about where his short clients will be able to come up with the shares they are obligated to buy back. MM doesn't really care, they are making a handsome profit keeping the market "liquid" and are more than willing to do some more Reverse Conversions when necessary to restore order. Get ready for some hit pieces or analyst notes this weekend or early next week bashing the stock in an effort to keep this below 7 through Feb expiration.
If we can be allowed to hypothesize about these past two days, maybe some big fund has been establishing a new position or possibly one of the institutional shorts are starting to cover. Could there be a leak of an upcoming partnership or Trial result?? Just purely guessing, but something energized this stock in a big way these past two days and I have no idea what the catalyst was.
Regardless of the the price run this week, ZIOP's IP has been validated by ongoing brain cancer trials, successful Sleeping Beauty trials, and the eagerness of Dr. Rossenburg of the NCI (and godfather of modern day immunology) so willing to collaborate with them to expedite ongoing clinical trials. Long term, ZIOP wins. Short term, we are far from out of the woods. Need news, trial data or a funding plan to move forward. |
